1432450-89-9

Basic information

• Product Name: N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(4-(piperidin-1-yl)phenyl)quinazolin-4-amine
• CAS NO: 1432450-89-9
• Molecular Weight: 539.052
• Mol File: 1432450-89-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(4-(piperidin-1-yl)phenyl)quinazolin-4-amine(CAS DataBase Reference)
• NIST Chemistry Reference: N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(4-(piperidin-1-yl)phenyl)quinazolin-4-amine(1432450-89-9)
• EPA Substance Registry System: N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(4-(piperidin-1-yl)phenyl)quinazolin-4-amine(1432450-89-9)

Safety Data

• Hazardous Substances Data: 1432450-89-9(Hazardous Substances Data)

Upstream product

• 22148-20-5 N-(4-bromophenyl)piperidine 
• 5326-47-6 2-amino-5-iodobenzoic acid 
• 16064-08-7 6-iodoquinazolin-4(3H)-one 
• 1373622-18-4 4-chloro-6-iodoquinazoline hydrochloride 

Relevant articles and documents

Kinase scaffold repurposing for neglected disease drug discovery: Discovery of an efficacious, lapatanib-derived lead compound for trypanosomiasis

Human African trypanosomiasis (HAT) is a neglected tropical disease caused by the protozoan parasite Trypanosoma brucei. Because drugs in use against HAT are toxic and require intravenous dosing, new drugs are needed. Initiating lead discovery campaigns b